Authors:
Grampp, S
Henk, C
Lu, Y
Krestan, C
Resch, H
Kainberger, F
Youssefzadeh, S
Vorbeck, F
Imhof, H
Citation: S. Grampp et al., Quantitative US of the calcaneus: Cutoff levels for the distinction of healthy and osteoporotic individuals, RADIOLOGY, 220(2), 2001, pp. 400-405
Authors:
Raderer, M
Kurtaran, A
Leimer, M
Angelberger, P
Niederle, B
Vierhapper, H
Vorbeck, F
Hejna, MHL
Scheithauer, W
Pidlich, J
Virgolini, I
Citation: M. Raderer et al., Value of peptide receptor scintigraphy using I-123-vasoactive intestinal peptide and In-111-DTPA-D-Phe(1)-octreotide in 194 carcinoid patients: Vienna university experience, 1993 to 1998, J CL ONCOL, 18(6), 2000, pp. 1331-1336
Authors:
Vorbeck, F
Cartellieri, M
Ehrenberger, K
Imhof, H
Citation: F. Vorbeck et al., Intraoperative computer aided navigation in ENT sinus surgery using Philips "NEUROGUIDE" system, RADIOLOGE, 40(3), 2000, pp. 227-232
Citation: M. Cartellieri et F. Vorbeck, Endoscopic sinus surgery using intraoperative computed tomography imaging for updating a three-dimensional navigation system, LARYNGOSCOP, 110(2), 2000, pp. 292-296
Authors:
Raderer, M
Vorbeck, F
Formanek, M
Osterreicher, C
Valencak, J
Penz, M
Kornek, G
Hamilton, G
Dragosics, B
Chott, A
Citation: M. Raderer et al., Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma, BR J CANC, 83(4), 2000, pp. 454-457
Authors:
Raderer, M
Valencak, J
Pfeffel, F
Drach, J
Pangerl, T
Kurtaran, A
Hejna, M
Vorbeck, F
Chott, A
Virgolini, I
Citation: M. Raderer et al., Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type, J NAT CANC, 91(8), 1999, pp. 716-718
Authors:
Vorbeck-Meister, I
Sommer, R
Vorbeck, F
Horl, WH
Citation: I. Vorbeck-meister et al., Quality of water used for haemodialysis: bacteriological and chemical parameters, NEPH DIAL T, 14(3), 1999, pp. 666-675
Authors:
Stoiser, B
Vorbeck, F
Kofler, J
Locker, GJ
Burgmann, H
Citation: B. Stoiser et al., Placement of a pulmonary artery catheter via a previously unrecognized persistent left superior vena cava, VASA, 28(1), 1999, pp. 53-54
Authors:
Raderer, M
Hamilton, G
Kurtaran, A
Valencak, J
Haberl, I
Hoffmann, O
Kornek, GV
Vorbeck, F
Hejna, MHL
Virgolini, I
Scheithauer, W
Citation: M. Raderer et al., Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results, BR J CANC, 79(3-4), 1999, pp. 535-537
Authors:
Raderer, M
Hejna, MHL
Kurtaran, A
Kornek, GV
Valencak, JB
Oberhuber, G
Vorbeck, F
Virgolini, I
Scheithauer, W
Citation: M. Raderer et al., Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide, AM J GASTRO, 94(1), 1999, pp. 278-279
Authors:
Leimer, M
Kurtaran, A
Smith-Jones, P
Raderer, M
Havlik, E
Angelberger, P
Vorbeck, F
Niederle, B
Herold, C
Virgolini, I
Citation: M. Leimer et al., Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma, J NUCL MED, 39(12), 1998, pp. 2090-2094